James Ziai

9.9k citations
29 papers · 1.2k indexed · h-index 14
Topics
Cancer Immunotherapy and Biomarkers (8 papers)Cancer Cells and Metastasis (4 papers)Immunotherapy and Immune Responses (4 papers)

In The Last Decade

James Ziai

27 papers receiving 1.2k citations

Peers

James Ziai
Comparison fields: 5 of 104
  • Molecular Biology 371
  • Oncology 350
  • Physical Therapy, Sports Therapy and Rehabilitation 250
  • Immunology 242
  • Psychiatry and Mental health 211
Replace Keisuke Mizuta with:
Keisuke Mizuta Japan
Takashi Kasahara Japan
Takeya Ono Japan
Martin Chovanec Czechia
Akiko Misawa Japan
Marco Alessandrini South Africa
Svetlana Egorova United States
E. Sindern Germany
So Young Ahn South Korea
Luisa Caniatti Italy
James Ziai relative to Keisuke Mizuta Japan Keisuke Mizuta's profile →
Citations per field
00.5×6.1×
Keisuke Mizuta · 1×
Citations per year

Countries citing papers authored by James Ziai

Since Specialization
Citations

This map shows the geographic impact of James Ziai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Ziai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Ziai more than expected).

Fields of papers citing papers by James Ziai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Ziai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Ziai. The network helps show where James Ziai may publish in the future.

Co-authorship network of co-authors of James Ziai

This figure shows the co-authorship network connecting the top 25 collaborators of James Ziai. A scholar is included among the top collaborators of James Ziai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Ziai. James Ziai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 2
4 2
5 19
6 18
7 139
8 2
9 9
10 156
11 34
12 75
13 1
14 44
15 30
16 8
17 7
18 57
19 79
20 407

About James Ziai

James Ziai is a scholar working on Oncology, Cancer Research and Immunology, having authored 29 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Cancer Cells and Metastasis (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Physical Therapy, Sports Therapy and Rehabilitation (250 citations), Rehabilitation (101 citations) and Psychiatry and Mental health (211 citations). James Ziai has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Mitchell Batavia, Andrew L. McDonough, Matthew L. Albert, Pei Hui, Jérémie Decalf, Natália Buza, Stanislas Pol, Binfeng Lu, Vincent Mallet and Valérie Paradis. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Genes & Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026